End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.85 CNY | +3.58% | +2.39% | -21.26% |
Business Summary
Number of employees: 476
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Crude Urokinase
43.0
%
| 103 | 42.3 % | 177 | 43.0 % | +71.46% |
Ulinastatin Crude
19.3
%
| 40 | 16.4 % | 80 | 19.3 % | +98.15% |
Senna Granules
15.6
%
| 50 | 20.3 % | 64 | 15.6 % | +29.63% |
New HIV Drug (Enomitide Tablets)
11.9
%
| - | - | 49 | 11.9 % | - |
New HIV Drug (EnovirineTablets)
6.0
%
| 33 | 13.7 % | 25 | 6.0 % | -26.15% |
HIV Diagnostic Reagents
1.8
%
| 12 | 5.0 % | 7 | 1.8 % | -40.95% |
Bacillus Cereus Tablets
1.0
%
| 3 | 1.4 % | 4 | 1.0 % | +19.19% |
Other Crude Human Protein
0.8
%
| 0 | 0.0 % | 3 | 0.8 % | +6,509.67% |
Other Business
0.6
%
| 1 | 0.6 % | 2 | 0.6 % | +69.38% |
Other Generic Drugs
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | -997.00% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 244 | 100.0 % | 411 | 100.0 % | +68.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Chuanhong Zhu
DFI | Director of Finance/CFO | 53 | 23-09-15 |
He Liang Fu
CHM | Chairman | 63 | 13-12-31 |
Qi Hong
CTO | Chief Tech/Sci/R&D Officer | 61 | 21-01-18 |
Jun Wang
COO | Chief Operating Officer | 50 | 13-12-31 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 14-12-31 |
Wei Xuan Zhou
IRC | Investor Relations Contact | 34 | 20-07-31 |
Yan Liu
SEC | Corporate Secretary | 42 | 23-03-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
He Liang Fu
CHM | Chairman | 63 | 13-12-31 |
Guang Ji Wang
BRD | Director/Board Member | 71 | 19-05-08 |
Xiao Yan Qi
BRD | Director/Board Member | 61 | 22-03-09 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 14-12-31 |
Jun Wang
COO | Chief Operating Officer | 50 | 13-12-31 |
Heng Yu
CHM | Chairman | 44 | 09-11-30 |
Feng Ying He
BRD | Director/Board Member | 41 | 14-11-30 |
Zijian Guo
BRD | Director/Board Member | 63 | 23-09-14 |
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 420,782,808 | 185,754,481 ( 44.14 %) | 0 | 44.14 % |
Company contact information
Jiangsu Aidea Pharmaceutical Co., Ltd.
No.69 New Ganquan West Road Hanjiang District
225008, Yangzhou
+
http://www.aidea.com.cnSector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.26% | 550M | |
+3.84% | 97.02B | |
+6.18% | 40.94B | |
-10.57% | 33.35B | |
+83.78% | 29.53B | |
-14.04% | 15.76B | |
-3.70% | 13.65B | |
-12.70% | 11.44B | |
+174.11% | 10.08B | |
+6.14% | 9.06B |
- Stock Market
- Equities
- 688488 Stock
- Company Jiangsu Aidea Pharmaceutical Co., Ltd.